Skip to main content

Open

Assisting Specialty Crop Exports: Low Oxygen Storage and Packaging Systems for U.S. Tree Nuts with Phytosanitary Traceability

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
An individual applicant may not submit more than one application in response to this NOFO and may not be offered more than one award.

Executive Summary
The U.S. Department of Agriculture, Foreign Agricultural Service announces this notice of funding opportunity (NOFO) to support the Assisting Specialty Crop Exports (ASCE) Initiative by issuing a new award. The award is contingent on the availability of funding. This initiative aims to enhance U.S. specialty crop market access in key export markets and support producers with cost-effective approaches for post-harvest pest control and maintaining quality during storage and export. This opportunity is available to U.S. academic institutions, nonprofits with or without 501(c)(3) designation, U.S. trade associations, U.S. agricultural cooperatives, international organizations based in the United States, and any other United State-based entity including private sector businesses. The award is intended to assist U.S. tree nut and durable specialty crop producers and agribusinesses by developing the processes and technologies for phytosanitary validation and traceability of low-oxygen storage and packaging systems. Applicants must be registered in SAM.gov and apply through USDA’s ezFedGrants online system, both of which require an identity-proofed login.gov account. 

Benefits to the United States: 

  • This program makes America more prosperous by strengthening trade. 
  • This program makes America more prosperous by expanding and developing new markets in current and potential trading partners.

Long-term health outcomes of people living with spina bifida

Request Ticket (Include Component) // Limit: 2 (Component A or B) // Tickets Available: 2

Limiting Language
You must follow these limits on the number of applications your organization can submit.

You may apply to either Component A or Component B, or both. Each organization (normally identified by having a unique UEI number) may submit one application for each component. So, at the most, you may submit two applications.

Summary
This NOFO has two funding components:

  • Component A: National Spina Bifida Patient Registry (NSBPR).
  • Component B: Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida (UMPIRE).

The purpose of this NOFO is to:

  • Component A: Collect high-quality longitudinal data on children and adults with spina bifida (SB) who get care in specialized SB clinics that are part of the National Spina Bifida Patient Registry (NSBPR).
  • Component B: Carry out and evaluate the Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida (UMPIRE) iterative protocol in infants and young children with myelomeningocele. Building on existing longitudinal data collection, recipients will collect and analyze data on patients with SB to:
    • Better understand health outcomes after interventions and treatments.
    • Share findings to identify opportunities to improve care of patients with SB.

You may apply to either Component A or Component B, or both.

Funding Type
External Deadline
10/26/2026

2027 St. Baldrick’s Foundation Research Grant Awards

Request Ticket // Limit: 1* (additional application possible for cancer types specified below) // Tickets Available: 1


Limiting Language

  • Each institution may submit one (1) LOI/application in each open St. Baldrick’s funding category. 
  • ATTENTION:  St. Baldrick’s Foundation has identified the areas below as funding interests and has donors interested in supporting meritorious projects in these areas. To encourage submissions in these priority areas, institutions may submit one additional LOI beyond the standard limited submissions. Only one additional submission is permitted per institution for the entire cycle (Research, Scholar, International Scholar or Survivorship & Supportive Care Research Grant); this does not allow one additional submission in each program or funding category. 
    • Brain tumors – all types, including rare forms, especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM) 
    • Burkitt lymphoma – all types, especially sporadic 
    • Rhabdoid tumors - Extrarenal 
  • Applications submitted in the above funding interest areas will be considered in a separate study section. 

Program Overview
These grants are for specific two-year research projects which are hypothesis driven and may be either laboratory, clinical, or epidemiological in nature. Please submit a realistic budget for the project. Grants will be $100,000/year or less, for two years.

 

Funding Type
External Deadline
10/16/2026 (Required LOI); 3/5/2027 (Invited Full Proposal)
Solicitation Type

Wetland Mitigation Banking Program Fiscal Year (FY) 2026

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
An applicant organization may not submit more than one application for different projects or proposing different approaches.

Executive Summary
NRCS is announcing the availability of $3 million in WMBP grant funds for the development and establishment of mitigation banks and banking opportunities solely for agricultural producers with wetlands subject to the wetland conservation compliance provisions of the Food Security Act of 1985 (as amended). WMBP is a competitive grants program accepting proposals from eligible entities as identified in Section B.1. Priority will be given to banks in states with significant numbers of individual wetlands, wetland acres, and conservation compliance requests. Based on NRCS data, these states are Georgia, Illinois, Indiana, Iowa, Michigan, Minnesota, Nebraska, Ohio, Pennsylvania, South Dakota, and Wisconsin.

Research Category
Funding Type
External Deadline
9/8/2026

Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed, provided that each application is scientifically distinct.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications from institutions/organizations that propose to establish core centers that are part of an integrated and existing program of nutrition and/or obesity research. The Nutrition Obesity Research Centers (NORC) program is designed to support and enhance the national research effort in nutrition and obesity. NORCs support three primary research-related activities: Research Core services, a Pilot and Feasibility (P and F) program, and a Scientific Catalyst program. All activities pursued by Nutrition Obesity Research Centers are designed to enhance the efficiency, productivity, effectiveness, and multidisciplinary nature of research in nutrition and obesity.

Funding Type
External Deadline
10/20/2026
Solicitation Type

Retirement Research Foundation Grants - November 2026 Deadline

Request Ticket // Limit: 1 LOI per College

College of Medicine - Tucson: Y. Shirai 
College of Medicine - Phoenix - S. Iyengar
College of Agriculture, Life and Environmental Sciences - K. White
College of Public Health - Z. Chen
College of Pharmacy - J. Lee

Limiting Language
Organizations may submit only one Letter of Inquiry per deadline. Common exceptions include LOIs submitted by separate departments of large universities. Per clarification with RRF, the University of Arizona may submit one LOI per college per deadline. 

Overview
RRF Foundation for Aging focuses on improving the quality of life for older people. In an effort to strengthen the Foundation’s impact, RRF has established Priority Areas. These Priority Areas are specific topics in aging that will be given higher priority within the Foundation’s grantmaking program.

Types of Grants

  1. Advocacy: Achieve enduring social change around issues that affect older Americans
  2. (Ineligible - for applicants in Illinois only) Direct Service: Improve availability and quality of community-based services and supports in seven states
  3. Research: Seek causes and solutions to significant problems for older persons
  4. Knowledge Sharing and Awareness Raising: Knowledge sharing and awareness-raising projects that convey meaningful information, shape narratives, and drive positive change. 
  5. (Ineligible - for applicants in Illinois only) Organizational Capacity Building: Improve management and governance of non-profit organizations

 

Funding Type
External Deadline
11/1/2026 (Required LOI)
Solicitation Type

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) - PAR-23-286, PAR-23-287

Request Ticket // Limit: 4* (see below) // Tickets Available: 2

Cancer Data Science // Limit: 1 // Tickets Available: 0
E. Ochoa Mora (Epidemiology and Biostatistics)

Cancer Control Science // Limit: 1 // Tickets Available: 0
J. Llavona-Ortiz (Cancer Center)

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Limiting Language
Each eligible institution (defined as having a unique UEI number or NIH IPF number) may submit up to a combined total of four applications (one in Cancer Data Science, one in Cancer Control Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer Research) to any companion NOFO or any combination of companion NOFOs (PAR-23-286, PAR-23-287, and/or PAR-23-288 (archived)).

Scientific Areas

  • (A) Cancer Data Science: For the purposes of this K99/R00 award, cancer data science is defined as an interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are both developed and used to extract knowledge and insights from increasingly large and/or complex sets of data. This includes cancer-focused data integration and visualization, systems biology, artificial intelligence, machine learning, informatics, genomics, precision oncology, and developing analytics for epidemiological or biostatistical studies.
  • (B) Cancer Control Science: For the purposes of this K99/R00 award, cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. This includes research in epidemiology, behavioral sciences, health services, surveillance, cancer survivorship, and healthcare policy.
  • (C) Molecular/Precision Cancer Prevention: For the purpose of this K99/R00 award, early translational research in cancer prevention is defined as basic research to understand mechanisms of cancer formation, development and progression of cancer precursors, and to translate basic biological knowledge into novel human interventions and human-centered adaption of current interventions with the potential to reduce cancer risk, incidence, and mortality, and improve quality of life. This includes but is not limited to research in molecular and systems biology, diagnostics, vaccine and drug development, pharmacology, and biomedical engineering.
  • (D) Other Cancer Research: For the purposes of this K99/R00 award, "Other Cancer Research" includes all scientific fields supported by the NCI that are not included in (A), (B) or (C). Applicants proposing research in (D) "Other Cancer Research" may apply only if it is reasonable to expect their candidates to transition to independence with an abbreviated period of mentored research training beyond their original doctoral degrees."
Funding Type
External Deadline
10/14/2026
Solicitation Type

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs. Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts

The RCC will lead, manage, and harmonize efforts for the Consortium including 1) providing management and administrative support; 2) providing leadership and expertise on statistical design and analysis, 3) providing research coordination with a central laboratory, 4) harmonizing data collection methods and use of common data elements, 5) developing the database; 6) conducting data management and data analyses for Consortium studies; and 7) fostering research collaborations. This NOFO uses a cooperative agreement mechanism (U24) and runs in parallel with a companion NOFO (RFA-DK-27-121).

Full sponsor guidelines are linked here. 
 

Funding Type
External Deadline
10/9/2026
Solicitation Type

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.


Purpose
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs.  Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts. 

Full sponsor guidelines are linked here. 

Funding Type
External Deadline
10/9/2026
Solicitation Type